Advisory Research’s P3 Health Partners Inc Warrant PIIIW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-65,835
Closed -$5.27K 475
2023
Q1
$5.27K Hold
65,835
﹤0.01% 345
2022
Q4
$9.22K Hold
65,835
﹤0.01% 357
2022
Q3
$49K Sell
65,835
-1,517
-2% -$1.09K ﹤0.01% 329
2022
Q2
$34K Sell
67,352
-30,348
-31% -$35.8K ﹤0.01% 329
2022
Q1
$155K Hold
97,700
0.01% 347
2021
Q4
$103K Buy
+97,700
New +$118K 0.01% 317

Other funds holding PIIIW

Advisory Research's PIIIW Position: Q2 2023 in Review

Advisory Research sold out of P3 Health Partners Inc Warrant (PIIIW) in Q2 2023, closing a stake of 65,835 shares — an estimated $5.27K sold.

Advisory Research first reported a position in PIIIW in Q4 2021 and held it in 6 quarters. The position peaked at $155K in Q1 2022. 22 funds tracked by Wall St. Rank hold PIIIW as of Q2 2023.

  • Advisory Research reported no remaining P3 Health Partners Inc Warrant position as of Q2 2023 after selling out during the quarter.
  • Advisory Research sold 65,835 P3 Health Partners Inc Warrant shares in Q2 2023, an estimated $5.27K.
  • Advisory Research first reported a position in P3 Health Partners Inc Warrant in Q4 2021 and held it in 6 quarters.
  • Advisory Research's P3 Health Partners Inc Warrant position peaked at $155K in Q1 2022.
  • 22 funds tracked by Wall St. Rank held P3 Health Partners Inc Warrant as of Q2 2023.

Based on Advisory Research's 13F filing for Q2 2023, filed 14 Aug 2023.